MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    iPSC-Based Modeling of SCA12 for Targeted Therapeutic Screening

    B. Reddy, A. Gerutshang, R. Roy, R. Banerjee, S. Chowdhury, H. Kumar, S. Chattarji (Kolkata, India)

    Objective: 1. To identify a cohort of genetically confirmed SCA12 patients of Indian origin, derive iPSCs, progenitor cells and neurons from peripheral blood samples2. To…
  • 2024 International Congress

    Spinocerebellar Ataxia 34: ELOVL4 Recurrent Mutation in a Different Family

    K. Makhoul, R. Ramdhani (Little Neck, USA)

    Objective: We present a rare case of Spinocerebellar Ataxia 34 (SCA 34) in a Vietnamese patient. Background: SCA 34 is a subtype of Spinocerebellar Ataxia…
  • 2024 International Congress

    Spectrum of polysomnographic abnormalities in a cohort of sporadic late onset ataxia patients

    A. Das, A. Jaryal, A. Srivastava (New Delhi, India)

    Objective: To evaluate the occurrence of rapid eye movement behavioral disorder (RBD) and associated polysomnographic abnormalities in patients of sporadic adult onset ataxia Background: Sporadic…
  • 2024 International Congress

    Motor Onset of Parkinson’s disease: the proximal limbs are first

    MA. Ruiz Yanzi, M. Matarazzo, T. Jiménez-Castellanos, JA. Pineda-Pardo, MHG. Monje, A. Sánchez-Ferro, C. Gasca-Salas, R. Martínez-Fernández, JA. Obeso (Madrid, Spain)

    Objective: To determine if proximal body parts are more affected than distal body parts at the clinical onset of Parkinson’s disease (PD). Background: Motor features…
  • 2024 International Congress

    Comparative Analysis of GAITRite and Moticon Digital Insoles for Gait Assessment in Parkinson’s Disease Patients Before and After Levodopa Administration

    R. Acosta, B. Kuyani, S. Stuart, A. Avbersek, P. Rai, S. Mishra, K. Kwei, D. Hall, N. Desai, S. Hamon, J. Urbanek, R. Alaj, O. Harari, M. Wipperman, O. Levy (Tarrytown, USA)

    Objective: Parkinson’s disease (PD) is characterized by gait impairments, impacting patient mobility and quality of life. This study compares a reference gait measurement system, GAITRite (GR) against digital…
  • 2024 International Congress

    Identification of Fall Risk in Patients with Parkinson’s Disease Through Telemonitoring

    F. Kanellos, G. Rigas, A. Ntanis, N. Kostikis, S. Kontaxis, L. Liouta, C. Tsitsou, S. Konitsiotis (Ioannina, Greece)

    Objective: This work presents an analysis of real-world, device-reported outcomes from patients with Parkinson’s disease (PD) in Greece. A total of 82 patients were included…
  • 2024 International Congress

    The study of evaluating the impact of simulating indoor environments using virtual reality on gait in Parkinson’s Disease

    K. Seo, S. Emoto, K. Abe, T. Ishii, M. Miki, M. Hara, T. Yamamoto (Saitama, Japan)

    Objective: This study aims to quantitatively assess how indoor environments affect on gait disturbances in PD patients using virtual reality (VR). Background: Patients with Parkinson's…
  • 2024 International Congress

    The impact of Deep Brain Stimulation for Parkinson’s disease on Quality of Life

    M. Schiess, S. Bick, J-P. Azulay, S. Palfi, T. Witt, A. López Ríos, F. Farrokhi, B. Bretscher, G. Hilleren, T. Weaver (Houston, USA)

    Objective: To evaluate the long-term outcomes in Quality of Life (QoL) for patients with Parkinson’s disease (PwP) enrolled in a global, real-world device registry for…
  • 2024 International Congress

    Microstructural Changes in the Inferior Tuberal Hypothalamus Correlate with Daytime Sleepiness in Lewy Body Disease

    J. Cohen, H. Radhakrishnan, C. Olm, S. Das, P. Cook, D. Wolk, D. Weintraub, D. Irwin, C. Mcmillan (Philadelphia, USA)

    Objective: Identify neuroimaging correlates of excessive daytime sleepiness in Lewy body disorders using diffusion MRI. Background: Excessive daytime sleepiness (EDS) is a common and disabling…
  • 2024 International Congress

    Characterisation of the pharmacokinetic profile of amantadine in the common marmoset

    D. Bédard, F. Gaudette, S. Nuara, F. Beaudry, P. Huot (Montreal, Canada)

    Objective: To determine the pharmacokinetic (PK) profile of amantadine in the common marmoset (Callithrix jacchus). Background: Amantadine is currently approved for the treatment of L-3,4-dihydroxyphenylalanine…
  • « Previous Page
  • 1
  • …
  • 455
  • 456
  • 457
  • 458
  • 459
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley